arrow
返回
J

Josep Tabernero

instituto de salud carlos iii

146H指数
2.7K论文数
12.7W被引数
收录论文 690
发表时间
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial循环肿瘤DNA指导的高风险II期和III期结肠癌辅助治疗降级或升级:PEGASUS II期试验
err2026-09-14
err0
errOAAI
errSilvia Marsoni; Clara Montagut; Filippo Pietrantonio; Andrea Sartore-Bianchi; Luca Lazzari; Francesca Bergamo; Maria Giulia Zampino; Noelia Tarazona; Mario Mandalà; Stefano Tamberi; Elena Elez; Cristina Santos Vivas; Paolo Luraghi; Michele Prisciandaro; Federica Tosi; Davide Ciardiello; Joana Vidal; Victor Seguì; Michele Palazzo; Giulia Maddalena; Katia Bencardino; Ida Taglialatela; Marta Guix; Eliana Rulli; Valentina Vettore; Federica Morano; Claudio Isella; Giovanni Crisafulli; Giorgio Patelli; Enzo Medico; Alberto Bardelli; Andrés Cervantes; Valter Torri; Josep Tabernero; Salvatore Siena; Sara Lonardi
err分享
err收藏
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3随机对照研究:比较恩考拉非尼、西妥昔单抗和FOLFIRI方案与FOLFIRI联合或不联合贝伐珠单抗治疗BRAF V600E突变型结直肠癌——BREAKWATER队列研究3组
err2026-05-31
err0
errOAAI
errS. Kopetz; J. Tabernero; S. Lonardi; L. Shen; H.S. Wasan; T. Yoshino; E. Van Cutsem; T.W. Kim; C. Eng; F. Ciardiello; J. Desai; T.S. Maughan; R. Yaeger; T. Usari; Xiaoxi Zhang; E. Beyzarov; A. Mori; E. Whalley; Xiaosong Zhang; E. Elez
err分享
err收藏
Quality and safety of research biopsies in oncology clinical trials.肿瘤临床试验中研究活检的质量与安全。
err2026-05-25
err0
errOAAI
errPaolo Nuciforo; Fiorella Ruiz-Pace; José Jimenez; Raquel Comas; Roberta Fasani; Cristina Viaplana; Cesar Sevillano; Paola Martinez; Xavier Serres-Créixams; Nuria Roson; Cristina Saura; Elena Elez; Ana Oaknin; Irene Braña Garcia; Eva Muñoz-Couselo; Teresa Macarulla Mercade; Joan Carles; Josep Tabernero; Enriqueta Felip; Elena Garralda
err分享
err收藏
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors塞格图单抗阿穆纳鲁金的安全性与药代动力学、药效学及抗肿瘤活性:一项针对晚期和/或转移性实体瘤患者的I期研究
err2026-05-13
err0
errOAAI
errU. Lassen; E.M.J. van Brummelen; I. Melero; E. Angevin; H. Joensuu; N.H. Segal; M. Mau-Sørensen; N. Steeghs; M.E. Rodríguez-Ruiz; K. Homicsko; J. Tabernero; M. Cañamero; D. Dejardin; C. Habigt; E. Rossmann; E. Guarin; G. Babitzki; H.E.S. Baumann; A.P. Silva; C. Adessi
err分享
err收藏
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure表观遗传指纹将早发性结肠癌和直肠癌与农药暴露联系起来
err2026-04-21
err0
errOAAI
errSilvana C. E. Maas; Iosune Baraibar; Lea Lemler; Maria Butjosa-Espín; Odei Blanco Irazuegui; Josep Tabernero; Elena Elez; Jose A. Seoane
err分享
err收藏
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients基因组景观、靶向疗法及耐药机制在分子选择转移性结直肠癌患者中的应用
errGenes
IF2.8
err2026-04-15
err0
errOAAI
errPatricia Garcia Pastor; Nadia Saoudi González; Francesc Salva; Javier Ros; Iosune Baraibar; Marta Rodríguez Castells; Clara Salva de Torres; Ariadna García; Adriana Alcaraz; Caterina Vaghi; Josep Tabernero; Elena Elez
err分享
err收藏
New prognostic and predictive scoring systems for colorectal cancer liver metastases结直肠癌肝转移的新预后和预测评分系统
err2026-04-09
err0
errOAAI
errF. Salvà; S. Pérez Fernandez; C. Dopazo; M. Salcedo; N. Saoudi; M. Rodriguez; I. Baraibar; J. Ros; C. Salva de Torres; C. Vaghi; Z. Calixto; C. Gómez-Gavara; M. Caralt; G. Sapisochin; J. Tabernero; E. Elez
err分享
err收藏
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities开发基于证据、具有成本效益的P4癌症医学,以推动在预防、治疗、患者护理方面的创新,并减少医疗不平等。
err2025-12-15
err0
errOAAI
errUlrik Ringborg; Joachim von Braun; Julio Celis; Anton Berns; Michael Baumann; Tit Albreht; Nancy Abou-Zeid; Vanderlei Bagnato; Christian Brandts; Chien-Jen Chen; Massimiliano di Pietro; Manjit Dosanjh; Thomas Dubois; Alexander Eggermont; Angelika Eggert; Ingemar Ernberg; Sara Faithfull; Johannes Förner; Stefan Fröhling; Manuel Heitor; Leroy Hood; Wei Jiang; Bengt Jönsson; Ravi Kannan; Maria Leptin; Su Li; Peter Lindgren; Douglas Lowy; Jun Ma; Alex Markham; Péter Nagy; Simon Oberst; M. Iqbal Parker; Danielle Rodin; Kevin Ryan; Joachim Schüz; Richard Sullivan; Josep Tabernero; Peter Turkson; Oliver Várhelyi; Harold Varmus; Chijie Wang; Elisabete Weiderpass; Nils Wilking
err分享
err收藏
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up替雷利珠单抗 + 化疗在胃癌中的应用:长期RATIONALE-305随机试验随访
err2025-11-18
err0
errOAAI
errMarcia Cruz-Correa; Do-Youn Oh; Ken Kato; Josep Tabernero; Yuxian Bai; Jianhua Shi; Keun-Wook Lee; Hidekazu Hirano; David Spigel; Lucjan Wyrwicz; Roberto Pazo Cid; Antonio Cubillo Gracián; Yaling Xu; Tao Sheng; Silu Yang; Rui-Hua Xu; Markus Moehler
err分享
err收藏
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors基因组可操作性及匹配的靶向疗法在为期十年的机构实体瘤精准医学项目中的应用
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
err分享
err收藏
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trialZanzalintinib联合atezolizumab与regorafenib对比治疗难治性结直肠癌(STELLAR-303):一项随机、开放标签、III期临床试验
err2025-10-20
err0
PREAI
errJ Randolph Hecht; Young Suk Park; Josep Tabernero; Myung-Ah Lee; Soohyeon Lee; Anna C Virgili; Marc Van den Eynde; Elisa Fontana; Marwan Fakih; Gholamreza Asghari; Jane So; Alexander Stein; Olivier Dubreuil; Lubomir Bodnar; Cixin Steven He; Guan Wang; Robina Smith; Cathy Eng; Anwaar Saeed
err分享
err收藏
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialPD1疗法在PD1高表达mRNA肿瘤中的疗效:SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果
err2025-09-30
err0
errOAAI
errE. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
err分享
err收藏
Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects在加泰罗尼亚公共健康体系中实施精准肿瘤学计划:结果、经验教训及未来展望
err2025-09-03
err0
errOAAI
errPilar Mur; Anna Pozuelo; Josep Tabernero; Joan Albanell; Beatriz Bellosillo; Francesc Bosch; Javier Briones; Joan Brunet; Dolors Colomer; Montserrat Domènech; Joan Manel Fontanet; Xavier Matias-Guiu; Ramon Salazar; Rosa Maria Vivanco-Hidalgo; Meritxell Mollà; Lucas Moreno; Aleix Prat; Josep Maria Ribera; Ramón Clèries; Alex Guarga; Josep A. Espinàs; Josep Maria Borras
err分享
err收藏
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases―the PURPLE trial术前使用阿替利珠单抗和 tiragolumab 免疫疗法治疗结直肠癌肝转移患者——PURPLE 研究
err2025-09-01
err0
errOAAI
errKasper, S.; Elez, E.; Neumann, U.; Lang, S.; Trampe, A. -K.; Salva, F.; Dopazo, C.; Virchow, I.; Hartmann, S.; Herrmann, K.; Tabernero, J.; Westendorf, A.; Schuler, M.; Schramm, A.
err分享
err收藏
Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches区分结直肠癌中低肿瘤负荷与寡转移性疾病:对个体化治疗方法的呼吁
err2025-08-12
err0
errOAAI
errM.C. de Grandis; I. Baraibar; O. Prior; M. Balaguer-Montero; F. Salvà; J. Ros; M. Rodríguez-Castells; J. Tabernero; S. Lonardi; R. Perez-Lopez; E. Élez
err分享
err收藏
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON studyBEACON研究中BRAF V600E突变型结直肠癌患者肿瘤分子变化的通俗性摘要
err2025-05-09
err0
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
err分享
err收藏
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)MEK1/2抑制剂比尼美替尼与MET抑制剂克唑替尼在RAS突变型晚期结直肠癌 (汞) 患者中的Ia/b期研究
err2025-04-10
err0
errOAAI
errAroldi, Francesca; Elez, Elena; Andre, Thierry; Perkins, Geraldine; Prenen, Hans; Popovici, Vlad; Gallagher, Peter; Houlden, Jennifer; Collins, Linda; Roberts, Corran; Rolfo, Christian; Di Nicolantonio, Federica; Grayson, Margaret; Boyd, Ruth; Bettens, Karolien; Delfavero, Jurgen; Coyle, Victoria; Lawler, Mark; Khawaja, Hajrah; Laurent-Puig, Pierre; Salto-Tellez, Manuel; Maughan, Tim S.; Tabernero, Josep; Adams, Richard; Jones, Robert; Hennessy, Bryan T.; Bardelli, Alberto; Peeters, Marc; Middleton, Mark R.; Wilson, Richard H.; Van Schaeybroeck, Sandra
err分享
err收藏
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2fruquintinib联合最佳支持治疗用于转移性结直肠癌患者的质量调整生存:FRESCO-2研究的结果
err2025-03-01
err0
errOAAI
errStintzing, S.; Tabernero, J.; Satoh, T.; Dasari, A.; Lonardi, S.; Eng, C.; Garcia-Carbonero, R.; Elez, E.; Yoshino, T.; Sobrero, A. F.; Yao, J. C.; Kasper, S.; Arnold, D.; Basic, E.; Granold, M.; Petschulies, M.; Wu, L.; Chung, Y. -C; Chen, L.; Yang, Z.; Van Cutsem, E.
err分享
err收藏